MedTrace Logo

Validity of the Vyntus CPX Metabolic Cart for Assessing Postprandial Energy Expenditure and Respiratory Exchange Ratio

NCT05100797 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2021-12-28

No results posted yet for this study

Summary

The aims of the present study are described below:

Aim 1: In-vitro measures to determine the validity, precision and accuracy of the Vyntus CPX metabolic cart assessed by:

1.1. Methanol burning tests. 1.2. Pure gas (nitrogen \[N2\] and carbon dioxide \[CO2\]) infusions to simulate both, constant and variable fluxes of oxygen consumption (VO2) and carbon dioxide production (VCO2) in different conditions and moments.

1. Immediately after or prior the methanol burning test (in a randomized order).
2. In separate days and time-periods.

Aim 2: In-vivo measures using the Vyntus CPX metabolic cart:

2.1. To assess the resting metabolic rate (RMR or resting energy expenditure \[REE\]) and respiratory exchange ratio (RER) day-to-day biological reproducibility (i.e. reliability) of the metabolic cart.

2.2. Further, the investigators will use an oral glucose tolerance test (OGTT) to determine the post-prandial day-to-day biological reproducibility (especifically the post-prandial RER) of the metabolic cart.

Conditions

  • Metabolic Syndrome

Interventions

DEVICE

Vyntus CPX

To study the validity, precision and accuracy of the Vyntus CPX metabolic cart using both, in-vitro and in-vivo (i.e., human study) measures.

Sponsors & Collaborators

  • Universidad de Granada

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-20
Primary Completion
2022-02-23
Completion
2022-03-23

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05100797 on ClinicalTrials.gov